Skip to main
MOH

Molina Healthcare (MOH) Stock Forecast & Price Target

Molina Healthcare (MOH) Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 0%
Buy 17%
Hold 75%
Sell 8%
Strong Sell 0%

Bulls say

Molina Healthcare is facing some challenges with their MAPD business due to undertarget margins and a projected $0.29 decrease in EPS in '26. However, without their MAPD business, they are still expected to have profitable performance and we assume their D-SNP book to run at $3-3.5K PMPM. The state's preference for awarding D-SNP contracts to insurers with an MA & Caid presence could pose a potential risk for Molina Healthcare's future growth.

Bears say

Molina Healthcare is facing significant challenges in its Medicaid business, which accounts for over half of its members. The company has a conservative outlook for its Medicaid membership, with a 2.6% decline as compared to its peers projecting larger declines. Additionally, Molina's optimistic assumptions for improvement in its marketplace MLR and cost leverage may be difficult to achieve in the current operating environment and could potentially lead to margin compression. The company also faces uncertainties and challenges in the near term, making it difficult to support its 2026 guidance.

Molina Healthcare (MOH) has been analyzed by 12 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 17% recommend Buy, 75% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Molina Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Molina Healthcare (MOH) Forecast

Analysts have given Molina Healthcare (MOH) a Hold based on their latest research and market trends.

According to 12 analysts, Molina Healthcare (MOH) has a Hold consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $166.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $166.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Molina Healthcare (MOH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.